IBRX — Immunitybio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Immunitybio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	96.1	317	107	266	150
Net Total Accounts Receivable
Net Total Receivables	4.99	1.33	1.89	3.17	2.65
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	112	334	141	294	185
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	90.7	119	190	183	170
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	221	469	362	504	383
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	68.1	369	501	58.3	54.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	341	711	810	1,091	872
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-120	-242	-447	-587	-489
Total Liabilities & Shareholders' Equity	221	469	362	504	383
Total Common Shares Outstanding